Pacific Biosciences of California, Inc. (BMV:PACB)

BMV:PACB Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	11.7	12.06	12.75	11.78	11.17
Revenue Growth (YoY)	-2.99%	-5.43%	8.23%	5.53%	20.09%
Cost of Revenue	8.99	9.51	9.45	12.16	6.71
Gross Profit	2.7	2.55	3.3	-0.38	4.46
Selling, General & Admin	21.33	31.23	39.19	49.24	46.9
Research & Development	16.69	25.35	26.92	21.94	21.26
Operating Income	-35.31	-54.03	-62.81	-71.56	-63.7
Interest Income	0.7	1.12	0.55	0.09	0.86
Interest Expense	-13.12	-7.74	-3.77	-15.55	-15.55
Other Non-Operating Income (Expense)	-2.39	-0.12	3.46	9.36	0.19
Total Non-Operating Income (Expense)	-14.8	-6.74	0.24	-6.1	-14.5
Pretax Income	-50.11	-60.77	-62.57	-77.66	-78.2
Provision for Income Taxes	-0.07	0.85	-0.08	0.05	0.01
Net Income	-50.05	-61.62	-62.49	-77.7	-78.21
Net Income to Common	-50.05	-61.62	-62.49	-77.7	-78.21
Free Cash Flow	-24.7	-41.23	-49.28	-47.93	-51.76
Gross Margin	23.12%	21.15%	25.90%	-3.23%	39.94%
Operating Margin	-301.85%	-448.03%	-492.51%	-607.37%	-570.53%
Profit Margin	-427.81%	-510.97%	-490.06%	-659.50%	-700.47%
FCF Margin	-211.17%	-341.91%	-386.46%	-406.77%	-463.56%
EBITDA	-31.89	-50.77	-59.81	-69.04	-60.7
EBITDA Margin	-272.60%	-421.05%	-468.99%	-586.00%	-543.69%
EBIT	-35.31	-54.03	-62.81	-71.56	-63.7
EBIT Margin	-301.85%	-448.03%	-492.51%	-607.37%	-570.53%
Effective Tax Rate	0.13%	-1.40%	0.12%	-0.06%	-0.01%

Updated Dec 31, 2024. Data Source: Fiscal.ai. Standard template. Financial Sources.